The LRRK2 p.L1795F variant causes Parkinson’s disease in the European population
(2025) In npj Parkinson's Disease 11(1).- Abstract
- LRRK2-PD represents the most common form of autosomal dominant Parkinson’s disease. We identified the LRRK2 p.L1795F variant in three families and six additional unrelated cases using genetic data from over 50,000 individuals. Carriers with available genotyping data shared a common haplotype. The clinical presentation resembles other LRRK2-PD forms. Combined with published functional evidence showing strongly enhanced LRRK2 kinase activity, we provide evidence that LRRK2 p.L1795F is pathogenic. © The Author(s) 2025.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/8ce07b08-7d30-4ea8-b88e-02654798dfd8
- author
- Lange, L.M.
; Brolin, K.
LU
and Fang, Zih-Hua
- author collaboration
- organization
- publishing date
- 2025
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- LRRK2, protein, unclassified drug, Article, enzyme activity, European, female, genotyping, human, male, Parkinson disease, whole genome sequencing
- in
- npj Parkinson's Disease
- volume
- 11
- issue
- 1
- article number
- 58
- publisher
- Springer Nature
- external identifiers
-
- scopus:105001136183
- pmid:40133296
- ISSN
- 2373-8057
- DOI
- 10.1038/s41531-025-00896-2
- language
- English
- LU publication?
- yes
- id
- 8ce07b08-7d30-4ea8-b88e-02654798dfd8
- date added to LUP
- 2026-03-04 14:19:21
- date last changed
- 2026-03-05 03:35:53
@article{8ce07b08-7d30-4ea8-b88e-02654798dfd8,
abstract = {{LRRK2-PD represents the most common form of autosomal dominant Parkinson’s disease. We identified the LRRK2 p.L1795F variant in three families and six additional unrelated cases using genetic data from over 50,000 individuals. Carriers with available genotyping data shared a common haplotype. The clinical presentation resembles other LRRK2-PD forms. Combined with published functional evidence showing strongly enhanced LRRK2 kinase activity, we provide evidence that LRRK2 p.L1795F is pathogenic. © The Author(s) 2025.}},
author = {{Lange, L.M. and Brolin, K. and Fang, Zih-Hua}},
issn = {{2373-8057}},
keywords = {{LRRK2; protein; unclassified drug; Article; enzyme activity; European; female; genotyping; human; male; Parkinson disease; whole genome sequencing}},
language = {{eng}},
number = {{1}},
publisher = {{Springer Nature}},
series = {{npj Parkinson's Disease}},
title = {{The LRRK2 p.L1795F variant causes Parkinson’s disease in the European population}},
url = {{http://dx.doi.org/10.1038/s41531-025-00896-2}},
doi = {{10.1038/s41531-025-00896-2}},
volume = {{11}},
year = {{2025}},
}